Demonstrações financeiras detalhadas de EyePoint Pharmaceuticals, Inc. (EYPT): demonstração de resultados, balanço patrimonial e fluxo de caixa. Acompanhe a evolução de margens, dívida, liquidez e rentabilidade ano a ano com até 20 anos de histórico.
Resumo da Análise
EyePoint Pharmaceuticals, Inc. registou receitas de $31.4M no último exercício, com um CAGR de 5 anos de -1.8%.
Margens dos últimos 12 meses: margem bruta 41.8%, margem operacional -113.7%, margem líquida -109.9%.
Ao preço atual de $3.45, EYPT apresenta lucros negativos (P/L não significativo) e um ROE de -75.78%. A capitalização de mercado é de $289M.
Demonstração de Resultados (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Receita | $7.5M | $3.0M | $5.9M | $20.4M | $34.4M | $36.9M | $41.4M | $46.0M | $43.3M | $31.4M |
| Custo da Receita | $815000 | 0 | $18.5M | $2.7M | $5.8M | $8.2M | $8.3M | $4.6M | $3.7M | $2.1M |
| Lucro Bruto | $6.7M | $3.0M | -$13.9M | $17.7M | $28.6M | $28.8M | $33.1M | $41.4M | $39.6M | $29.3M |
| P&D | $14.9M | $14.9M | $20.8M | $15.4M | $17.4M | $28.5M | $49.6M | $64.7M | $132.9M | $221.0M |
| Despesas Gerais e Administrativas | $11.2M | $11.2M | $31.5M | $47.7M | $46.0M | $53.1M | $60.3M | $51.8M | $52.5M | $51.7M |
| Despesas Operacionais | $24.8M | $29.2M | $52.3M | $65.5M | $65.9M | $84.0M | $132.7M | $116.5M | $185.4M | $272.7M |
| Lucro Operacional | -$18.1M | -$26.3M | -$49.1M | -$47.9M | -$37.3M | -$55.3M | -$99.6M | -$75.1M | -$145.9M | -$243.4M |
| EBITDA | -$17.7M | -$51.3M | -$46.5M | -$48.0M | -$35.5M | -$50.1M | -$96.6M | -$69.0M | -$129.2M | -$229.3M |
| Despesas com Juros | 0 | $720000 | $720000 | $6.2M | $7.3M | $5.5M | $3.2M | $1.2M | $14000 | 0 |
| Lucro Antes de Impostos | -$18.5M | -$53.2M | -$89.4M | -$56.8M | -$45.4M | -$58.4M | -$102.3M | -$70.7M | -$130.8M | -$231.7M |
| Imposto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $83000 | $90000 | $279000 |
| Lucro Líquido | -$18.5M | -$53.2M | -$53.2M | -$56.8M | -$45.4M | -$58.4M | -$102.3M | -$70.8M | -$130.9M | -$232.0M |
| LPA | $-5.23 | $-11.50 | $-12.71 | $-5.44 | $-3.54 | $-2.03 | $-2.74 | $-1.82 | $-2.32 | $-3.17 |
| LPA Diluído | $-5.20 | $-11.50 | $-11.50 | $-5.44 | $-3.54 | $-2.03 | $-2.74 | $-1.82 | $-2.32 | $-3.17 |
| Ações em Circulação (Diluídas) | $3.2M | $3.5M | $4.6M | $10.4M | $12.8M | $28.8M | $37.3M | $38.9M | $56.3M | $73.3M |
Demonstração de Resultados (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Receita | $966000 | $620000 | $696000 | $507000 |
| Lucro Bruto | $245000 | $245000 | $168000 | $507000 |
| Lucro Operacional | -$62.0M | -$70.3M | -$87.2M | -$97.4M |
| EBITDA | -$59.2M | -$57.9M | -$84.2M | -$93.1M |
| Lucro Líquido | -$59.7M | -$67.6M | -$84.8M | -$94.5M |
| LPA | $-0.85 | $-0.81 | $-0.99 | $-1.09 |
| LPA Diluído | $-0.85 | $-0.81 | $-0.99 | $-1.09 |
Balanço (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caixa e Equivalentes | $16.9M | $16.9M | $45.3M | $22.2M | $44.9M | $178.6M | $95.6M | $281.3M | $99.7M | $101.8M |
| Investimentos de Curto Prazo | $5.8M | 0 | 0 | 0 | 0 | $33.0M | $48.9M | $49.8M | $271.2M | $204.3M |
| Contas a Receber | $251000 | $353000 | $627000 | $11.4M | $9.5M | $18.4M | $15.5M | $805000 | $607000 | $651000 |
| Estoque | 0 | -$251000 | $279000 | $2.1M | $5.3M | $3.6M | $2.9M | $3.9M | $2.3M | $1.8M |
| Ativos Circulantes | $17.7M | $17.7M | $47.6M | $41.7M | $63.1M | $237.7M | $172.8M | $344.8M | $383.3M | $328.7M |
| Imobilizado | $290000 | $313000 | $253000 | $3.4M | $3.2M | $2.7M | $7.4M | $10.2M | $29.2M | $20.2M |
| Ágio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Ativos Intangíveis | $1.1M | $364000 | $31.4M | $27.7M | $25.2M | $22.7M | 0 | 0 | 0 | 0 |
| Ativos Totais | $18.7M | $18.7M | $78.2M | $73.0M | $91.7M | $263.4M | $180.4M | $355.2M | $418.5M | $364.0M |
| Contas a Pagar | $1.0M | $2.9M | $2.6M | $4.2M | $4.8M | $7.4M | $5.9M | $6.5M | $11.7M | $10.5M |
| Dívida de Curto Prazo | 0 | 0 | 0 | 0 | 0 | 0 | $10.5M | 0 | 0 | 0 |
| Passivos Circulantes | $5.3M | $5.3M | $21.5M | $11.5M | $14.9M | $23.7M | $34.5M | $63.3M | $49.0M | $37.0M |
| Dívida de Longo Prazo | 0 | $17.3M | $17.6M | $47.2M | $38.0M | $36.6M | $29.3M | 0 | 0 | 0 |
| Passivos Totais | $5.3M | $5.3M | $60.0M | $64.6M | $73.2M | $79.0M | $84.0M | $88.9M | $82.0M | $57.9M |
| Reservas | -$310.8M | -$364.0M | -$408.5M | -$465.3M | -$510.7M | -$569.1M | -$671.4M | -$742.1M | -$873.0M | -$1.10B |
| Patrimônio Líquido | $13.3M | $11.7M | $37.6M | $8.3M | $18.5M | $184.4M | $96.4M | $266.3M | $336.5M | $306.1M |
| Dívida Total | 0 | $17.3M | $17.3M | $50.6M | $41.0M | $39.2M | $46.3M | $4.9M | $21.9M | $22.8M |
| Dívida Líquida | -$16.9M | $411000 | -$28.0M | $28.4M | -$3.9M | -$172.4M | -$98.2M | -$326.1M | -$349.1M | -$283.3M |
| Capital de Giro | $12.4M | $12.4M | $26.1M | $30.2M | $48.2M | $214.1M | $138.3M | $281.5M | $334.3M | $291.6M |
Balanço (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caixa e Equivalentes | $74.6M | $101.8M | $77.7M | $110.5M |
| Ativos Totais | $251.7M | $364.0M | $288.2M | $228.2M |
| Passivos Totais | $51.5M | $57.9M | $57.7M | $61.8M |
| Patrimônio Líquido | $200.2M | $306.1M | $230.5M | $166.4M |
| Dívida Total | $23.3M | $22.8M | $22.3M | $22.4M |
Fluxo de Caixa (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Lucro Líquido | -$18.5M | -$18.5M | -$53.2M | -$56.8M | -$45.4M | -$58.4M | -$102.3M | -$70.8M | -$130.9M | -$232.0M |
| Depreciação e Amortização | $815000 | $815000 | $1.1M | $2.6M | $2.6M | $2.8M | $2.4M | $464000 | $1.5M | $2.3M |
| Compensação em Ações | $2.5M | $2.5M | $4.0M | $4.6M | $5.5M | $7.4M | $14.2M | $12.1M | $36.7M | $27.9M |
| Variação Capital de Giro | $318000 | $248000 | -$940000 | -$12.5M | $20.1M | -$1.7M | -$3.0M | $58.9M | -$27.8M | -$33.8M |
| Fluxo de Caixa Operacional | -$16.3M | -$20.5M | -$21.9M | -$56.7M | -$14.4M | -$50.1M | -$65.0M | $1.9M | -$126.2M | -$240.1M |
| CapEx | -$113000 | -$147000 | -$108000 | -$213000 | -$362000 | -$156000 | -$2.1M | -$3.5M | -$4.1M | -$3.3M |
| Aquisições | $33000 | -$16.8M | -$16.8M | 0 | 0 | 0 | -$558000 | -$168000 | 0 | $155000 |
| Recompra de Ações | 0 | 0 | 0 | -$131000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fluxo de Caixa Livre | -$16.4M | -$20.6M | -$22.0M | -$56.9M | -$14.8M | -$50.3M | -$67.2M | -$1.6M | -$130.3M | -$243.4M |
Fluxo de Caixa (Trimestral)
| Ano | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Fluxo de Caixa Operacional | -$59.4M | -$65.0M | -$80.5M | -$62.3M |
| CapEx | -$798000 | -$986000 | -$997000 | -$1.2M |
| Fluxo de Caixa Livre | -$60.2M | -$66.0M | -$81.5M | -$63.5M |
| Dividendos Pagos | 0 | 0 | 0 | 0 |
| Compensação em Ações | $6.4M | $6.7M | $11.6M | $10.4M |
Crescimento e Margens (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crescimento Receita (anual) | | -60.7% | +97.8% | +247.8% | +69.1% | +7.3% | +12.1% | +11.1% | -6.0% | -27.5% |
| Crescimento Lucro Líquido (anual) | | -187.6% | +0.0% | -6.8% | +20.1% | -28.7% | -75.0% | +30.8% | -84.9% | -77.2% |
| Crescimento LPA (anual) | | -119.9% | -10.5% | +57.2% | +34.9% | +42.7% | -35.0% | +33.6% | -27.5% | -36.6% |
| Variação de Ações (anual) | | +11.8% | +30.8% | +125.6% | +23.1% | +124.0% | +29.8% | +4.3% | +44.7% | +30.1% |
| Crescimento FCF (anual) | | -25.6% | -6.7% | -158.5% | +74.0% | -239.6% | -33.6% | +97.6% | -8001.9% | -86.8% |
| Margem Bruta | 89.2% | 100.0% | -237.9% | 86.8% | 83.1% | 77.9% | 79.9% | 89.9% | 91.4% | 93.4% |
| Margem Operacional | -240.1% | -887.3% | -838.8% | -235.0% | -108.3% | -149.6% | -240.6% | -163.1% | -337.1% | -776.0% |
| Margem EBITDA | -234.4% | -1732.6% | -793.5% | -235.8% | -103.1% | -135.8% | -233.4% | -149.9% | -298.6% | -731.1% |
| Margem Líquida | -245.2% | -1795.7% | -908.0% | -278.9% | -131.8% | -158.1% | -247.0% | -153.8% | -302.4% | -739.4% |
| Margem FCF | -217.9% | -697.0% | -375.9% | -279.5% | -43.0% | -136.0% | -162.2% | -3.5% | -301.1% | -775.8% |
| Taxa Efetiva de Imposto | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.1% | -0.1% | -0.1% |
Dados por Ação (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Ação | $-5.20 | $-5.84 | $-4.76 | $-5.46 | $-1.15 | $-1.75 | $-1.80 | $-0.04 | $-2.31 | $-3.32 |
| Dividendo por Ação | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Ações em Circulação (Básicas) | $3.2M | $3.5M | $4.6M | $10.4M | $12.8M | $28.8M | $37.3M | $38.9M | $56.3M | $73.3M |
O que olhar em Biotech
A maioria das biotechs pequenas perde dinheiro. Analisar com P/E não faz sentido — olha caixa e pipeline.
- Cash Runway — Meses de caixa ao ritmo atual de gasto. <18 meses = risco de diluição urgente
- Cash burn anual — Ritmo a que queimam caixa operacional. Comparar com posição de caixa para projetar runway
- Dívida Total — Biotech sem receita + dívida = receita para falência
- I+D / Capitalização — Quanto investem em pipeline vs valor da empresa — indicador de intensidade de pesquisa
- Market cap / Caixa — Se cota perto do caixa, o mercado dá ~0 valor ao pipeline — oportunidade ou armadilha
Rentabilidade
| Retorno sobre patrimônio | -75.78% |
| Retorno sobre capital investido | -73.99% |
| Retorno sobre ativos | -63.73% |
| Margem bruta | 41.77% |
| Margem operacional | -11365.22% |
| Margem líquida | -10994.73% |
Saúde financeira
| Dívida / Patrimônio | 0.13 |
| Liquidez corrente | 4.50 |
Índices Chave (10 anos)
| Ano | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/L | -5.41 | -1.49 | -1.64 | -2.85 | -1.86 | -6.03 | -1.28 | -12.70 | -3.21 | -5.76 |
| P/VP | 6.71 | 5.17 | 2.55 | 19.41 | 4.56 | 1.91 | 1.36 | 3.38 | 1.25 | 4.37 |
| P/V | 11.87 | 20.41 | 16.42 | 7.94 | 2.45 | 9.53 | 3.15 | 19.54 | 9.69 | 42.66 |
| Margem Bruta | 89.2% | 100.0% | -237.9% | 86.8% | 83.1% | 77.9% | 79.9% | 89.9% | 91.4% | 93.4% |
| Margem Operacional | -240.1% | -887.3% | -838.8% | -235.0% | -108.3% | -149.6% | -240.6% | -163.1% | -337.1% | -776.0% |
| Margem Líquida | -245.2% | -1795.7% | -908.0% | -278.9% | -131.8% | -158.1% | -247.0% | -153.8% | -302.4% | -739.4% |